Transmembrane Collagens in Neuromuscular Development and Disorders.

Area of Science:

• Cell Biology
• Neuroscience
• Developmental Biology

Background:

• Neuromuscular development relies on complex molecular interactions for motor axon targeting.
• Transmembrane collagens, particularly Membrane-Associated Collagens with Interrupted Triple Helices (MACITs), are increasingly recognized for their roles in neuromuscular formation.
• Collagen XXV and Collagen XIII are key MACITs involved in distinct aspects of neuromuscular development and function.

Purpose of the Study:

• To review recent advances in understanding the roles of transmembrane collagens in neuromuscular development.
• To explore the molecular mechanisms underlying the function of transmembrane collagens in the neuromuscular system.
• To highlight the implications of transmembrane collagen dysfunction in human neuromuscular disorders.

Main Methods:

• Literature review of studies on transmembrane collagens in neuromuscular development.
• Analysis of genetic and functional data from various model organisms, including humans and *C. elegans*.
• Synthesis of current knowledge on the roles of Collagen XXV, Collagen XIII, COL-99, and UNC-122.

Main Results:

• Collagen XXV is essential for motor axon growth during muscle development, and its mutations cause ocular motor disorders.
• Collagen XIII is vital for the formation and maintenance of neuromuscular junctions (NMJs), with dysfunction leading to congenital myasthenic syndrome.
• Transmembrane collagens exhibit conserved functions across species, with *C. elegans* models like COL-99 and UNC-122 demonstrating roles in motor innervation and NMJ integrity.

Conclusions:

• Transmembrane collagens are critical regulators of neuromuscular development, axon guidance, and neuromuscular junction stability.
• Understanding the molecular mechanisms of transmembrane collagens offers insights into the pathogenesis of congenital neuromuscular disorders.
• Further research into transmembrane collagens holds potential for therapeutic strategies targeting neuromuscular diseases.